7 completed, 5 recruiting, 3 unknown, 2 active not recruiting. 11 Not applicable, 8 Phase 2, 1 Phase 1, 1 Phase 3.
Follow Refractory Angina: new trials by email Literature Review of Refractory Angina trials Research Report on Refractory Angina
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. XC001, Sham (No Treatment) - Refractory Angina, Coronary Artery Disease | Phase 2 | Recruiting | XyloCor Therapeutics, Inc. | 106 | 2025-07-08 | 2026-09-11 |
| Wave Crossover ECP Study for Simplified Therapy External Counterpulsation - Chronic Stable Angina, Refractory Angina | Not applicable | Completed | Pression | 52 | 2024-09-26 | 2026-04-07 |
| Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina Bone marrow aspiration and a single intracoronary infusion of autologous bone marrow-derived mononuclear cells., Sham bone marrow aspiration and sham cell infusion (insertion of vascular access sheath). - Refractory Angina Pectoris, Refractory Angina | Phase 2 | Recruiting | Barts & The London NHS Trust | 110 | 2024-03-01 | 2026-01-07 |
| Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction. Coronary sinus reducer, Sham Procedure, Invasive coronary physiology - Refractory Angina, Microvascular Angina | Not applicable | Active not recruiting | Imperial College London | 54 | 2023-04-17 | 2026-08-17 |
| Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II Arm 1: treatment with Shockwave Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry - Refractory Angina | Not applicable | Recruiting | Shockwave Medical, Inc. | 380 | 2022-01-04 | 2026-09-30 |
| CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial CardiAMP Cell Therapy System, Sham Treatment - Refractory Angina, Chronic Myocardial Ischemia | Not applicable | Active not recruiting | BioCardia, Inc. | 343 | 2021-06-30 | 2026-01-06 |
| Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance Coronary Sinus Reducer, Placebo Procedure - Refractory Angina | Not applicable | Unknown | Imperial College London | 50 | 2021-05-21 | 2023-10-30 |
| COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina Coronary sinus reducer, Optimal medical therapy - Coronary Microvascular Disease, Refractory Angina | Not applicable | Recruiting | Johannes Gutenberg University Mainz | 144 | 2021-04-01 | 2023-09-28 |
| Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms Allopurinol 300 MG, Placebo oral tablet - Refractory Angina | Phase 2 / Phase 3 | Unknown | Ministry of Health, Brazil | 40 | 2021-03-03 | 2021-02-24 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina IMB-1018972, Placebo oral tablet - Refractory Angina | Phase 2 | Withdrawn | Imbria Pharmaceuticals, Inc. | 2020-05-01 | 2025-11-10 | |
| HARapan kiTa ECP (External Counter Pulsation) Study HARTEC Study External Counter Pulsation (ECP) therapy - Cardiac Rehabilitation, Angiogenesis | Not applicable | Unknown | National Cardiovascular Center Harapan Kita Hospital Indonesia | 50 | 2019-07-01 | 2020-06-16 |
| Cardiac Rehabilitation in Patients With Refractory Angina Cardiac Rehabilitation - Refractory Angina | Not applicable | Completed | Hospital Israelita Albert Einstein | 72 | 2016-01-01 | 2022-02-11 |
| Coronary Arteriogenetic Heparinized Exercise Physical rehabilitation, Heparin, Placebo - Refractory Angina, Chronic Stable Angina | Not applicable | Completed | Clinical Centre of Serbia | 32 | 2013-02-01 | 2020-05-13 |
| Lipoprotein Apheresis in Refractory Angina Study Lipoprotein Apheresis, Sham Apheresis - Refractory Angina, Raised Lipoprotein(a)>50mg/dL or >500mg/L | Not applicable | Completed | Imperial College London | 20 | 2013-02-01 | 2019-11-12 |
| Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization Neovac coronary sinus reducer - Refractory Angina | Not applicable | Recruiting | Tel-Aviv Sourasky Medical Center | 100 | 2011-08-30 | 2022-02-02 |
| Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA Neovasc Reducer, Control - Refractory Angina | Phase 2 | Completed | Shockwave Medical, Inc. | 104 | 2010-09-01 | 2013-11-25 |
| Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis Selected CD 133+ cells - Coronary Artery Disease, Refractory Angina | Phase 1 / Phase 2 | Completed | Pilar Jimenez Quevedo | 28 | 2008-05-01 | 2013-08-06 |
| Intramyocardial Delivery of Autologous Bone Marrow Mononuclear bone marrow derived cells - Refractory Angina | Phase 2 | Suspended | IRCCS San Raffaele | 13 | 2007-05-01 | 2012-02-02 |
| Study Protocol of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina Local sedation, Bone Marrow Aspiration, Minithoracotomy - Refractory Angina | Phase 2 | Completed | CellPraxis Bioengenharia Ltda. | 13 | 2005-07-01 | 2014-06-03 |
Angina Pectoris (19) · Coronary Artery Disease (4) · Angina, Stable (2) · Microvascular Angina (2) · Chest Pain (1) · Coronary Disease (1) · Myocardial Ischemia (1)
Cardiovascular Diseases (19) · Heart Diseases (19) · Neurologic Manifestations (19) · Pain (19) · Pathological Conditions, Signs and Symptoms (19) · Signs and Symptoms (19) · Vascular Diseases (19) · Chest Pain (18) · Myocardial Ischemia (18) · Arterial Occlusive Diseases (4) · Arteriosclerosis (4) · Coronary Disease (3)
Allopurinol (1) · Cardiac Rehabilitation (1) · Counterpulsation (1) · Heparin (1) · Protons (1) · Therapeutics (1) · salicylhydroxamic acid (1)
Imperial College London (3) · Shockwave Medical, Inc. (2) · Barts & The London NHS Trust (1) · BioCardia, Inc. (1) · CellPraxis Bioengenharia Ltda. (1) · Clinical Centre of Serbia (1) · Hospital Israelita Albert Einstein (1) · IRCCS San Raffaele (1) · Imbria Pharmaceuticals, Inc. (1) · Johannes Gutenberg University Mainz (1) · Ministry of Health, Brazil (1) · National Cardiovascular Center Harapan Kita Hospital Indonesia (1) · Pilar Jimenez Quevedo (1) · Pression (1) · Tel-Aviv Sourasky Medical Center (1)
United Kingdom (6) · United States (5) · Brazil (3) · Canada (2) · Belgium (1) · Denmark (1) · Germany (1) · Indonesia (1) · Israel (1) · Italy (1) · Netherlands (1) · Serbia (1) · Spain (1) · Sweden (1)
Adam Salamon (1) · Ade Meidian Ambari, MD,FIHA (1) · Amish Raval, MD (1) · Ana Djordjevic-Dikic, MD, PhD (1) · Anthony Mathur (1) · Branko Beleslin, MD, PhD (1) · Dudley Pennell, MB BChir MA MD FRCP (1) · Enio Buffolo, MD, PhD (1) · Eugenio Picano, MD, PhD (1) · Gregg W Stone, MD (1) · Luciana Janot de Matos, Dra (1) · Luis Henrique W Gowdak, MD, PhD (1) · Mahmoud Barbir, MB BCh, FRCP (1) · Nelson A Hossne Junior, MD, PhD (1) · Paul Chamberlin, MD (1)
PMID 11897431, PMID 16990385, PMID 18404725, PMID 23413981, PMID 24366073, PMID 25651246, PMID 28453721, PMID 32719097, PMID 34760951, PMID 35134662, PMID 38214677, PMID 38395338, PMID 38604209, PMID 38862073, PMID 39668004
2014 (1), 2018 (1)